Molecular scanning of the beta-3-adrenergic receptor gene in Pima Indians and Caucasians

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 3, 1999, Pages 175-180

  Silver, Kristi ^a,d   Walston, Jeremy ^a   Yang, Yufeng ^a   Pratley, Richard ^b   Ravussin, Eric ^b   Raben, Nina ^c   Shuldiner, Alan R ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

beta 3 adrenergic receptor; Genetics; Insulin resistance; Obesity; Type 2 diabetes mellitus

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; GUANINE; OLIGONUCLEOTIDE; THYMIDINE; TRYPTOPHAN;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; DONOR SITE; ETHNOLOGY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HYBRIDIZATION; INDIAN; INSULIN RESISTANCE; INTRON; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RNA SPLICING; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; THERMOGENESIS;

AMINO ACID SUBSTITUTION; ARGININE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER; SEQUENCE ANALYSIS; TRYPTOPHAN;

EID: 0032805252     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-7560(199905/06)15:3<175::AID-DMRR34>3.0.CO;2-Y     Document Type: Article

References (35)

1. Himms-Hagen J. Brown adipose tissue thermogenesis: interdisciplinary studies. FASEB J 1990; 4: 2890-2898.
2. Walston J, Silver K, Bogardus C, et al. Time of onset of noninsulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343-347.
3. Clement K, Vaisse C, Manning BS, et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352-354.
4. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-351.
5. Kurabayashi T, Carey DG, Morrison NA. The beta 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996; 45: 1358-1363.
6. Urhammer SA, Clausen JO, Hansen T, Pedersen O. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3-adrenergic receptor gene. Diabetes 1996; 45: 1115-1120.
7. Elbein SC, Hoffman M, Barrett K, et al. Role of the beta 3 adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 1996; 81: 4422-4427.
8. Gagnon J, Mauriege P, Roy S, et al. The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996; 98: 2086-2093.
9. Silver K, Walston J, Wang Y, Dowse G, Zimmet P, Shuldiner AR. Molecular scanning for mutations in the beta 3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4155-4158.
10. Kadowaki H, Yasuda K, Iwamoto K, et al. A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215: 555-560.
11. Fujisawa T, Ikegami H, Yamato E, et al. Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 1996; 39: 349-352.
12. Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M. Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995; 346: 1433-1434.
13. Garcia-Rubi E, Starling RD, Tchernof A, et al. Trp64Arg variant of the beta3-adrenoceptor and insulin resistance in obese postmenopausal women. J Clin Endocrinol Metab 1998; 83: 4002-4005.
14. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998; 83: 2441-2444.
15. Shima Y, Tsukada T, Nakanishi K, Ohta H. Association of the Trp64Arg mutation of the beta3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta 1998; 274: 167-176.
16. Fogelholm M, Valve R, Kukkonen-Harjula K, et al. Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women. J Clin Endocrinol Metab 1998; 83: 4246-4250.
17. Awata T, Katayama S. Genetic variation in the beta3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 1996; 19: 271-272.
18. Shiwaku K, Gao TQ, Isobe A, Fukushima T, Yamane Y. A Trp 64 Arg mutation in the beta3-adrenergic receptor gene is not associated with moderate overweight in Japanese workers. Metabolism 1998; 47: 1528-1530.
19. Buettner R, Schaffler A, Arndt H, et al. The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 1998; 83: 2892-2897.
20. Snitker S, Odeleye OE, Hellmer J, et al. No effect of the Trp64Arg beta 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue. Diabetologia 1997; 40: 838-842.
21. Tataranni PA, Pratley R, Shuldiner A, Ravussin E. Beta 3-adrenergic receptor gene variant and lipid metabolism in Pima Indians. Diabetologia 1997; 40: 123-124.
22. Li LS, Lonnqvist F, Luthman H, Arner P. Phenotypic characterization of the Trp64Arg polymorphism in the beta-3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996; 39: 857-860.
23. Umekawa T, Yoshida T, Sakane N, Kogure A, Kondo M, Honjyo H. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes 1999; 48: 117-120.
24. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD. Pharmacological characterization of a recently described human beta-3-adrenergic receptor mutant. Endocrinology 1996; 137: 2638-2641.
25. Pietri-Rouxel F, St John Manning B, Gros J, Strosberg AD. The biochemical effect of the naturally occurring Trp64→Arg mutation on human beta3-adrenoceptor activity. Eur J Biochem 1997; 247: 1174-1179.
26. World Health Organization. WHO Expert Committee on Diabetes Mellitus. Second report. (Technical Report Series no. 646.) Geneva: World Health Organization, 1980.
27. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: a Laboratory Manual (2nd edn). New York: Cold Spring Harbor, 1989.
28. Shuldiner AR, Perfetti R. The polymerase chain reaction: applications to endocrine research. In Handbook of Endocrine Research Technique, De Pablo F, Scanes CG, Weintraub BM (eds). San Diego, CA: Academic Press, 1998; 457.
29. Bijvoet SM, Hayden MR. Mismatch PCR: a rapid method to screen for the Pro207→Leu mutation in the lipoprotein lipase (LPL) gene. Hum Mol Genet 1992; 1: 541.
30. Celi FS, Walston J, Silver K, Shuldiner AR. Rapid synthesis of standards for allele-specific oligonucleotide hybridization. Trends Genet 1994; 10: 184-185.
31. Hoffstedt J, Poirier O, Thorne A, et al. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplo-type that is associated with moderate obesity and altered receptor function. Diabetes 1999; 48: 203-205.
32. Berkowitz DE, Nardone NA, Smiley RM, et al. Distribution of beta 3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 1995; 289: 223-228.
33. Sharp PA. Splicing of messenger RNA precursors. Science 1987; 235: 766-771.
34. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-635.
35. Nichols RC, Rudolphi O, Ek B, Exelbert R, Plotz PH, Raben N. Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions. Am J Hum Genet 1996; 59: 59-65.